Additional file 1 of A nationwide cohort study suggests clarithromycin-based therapy for Helicobacter pylori eradication is safe in patients with stable coronary heart disease and subsequent peptic ulcer disease

Abstract

Additional file 1. Supplemental Table 1. Risk of study outcomes including arrhythmia events comparing clarithormycin users vs. nonusers